Allylamine antifungal

5 marketed 6 in Phase 3

This page covers all Allylamine antifungal drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Squalene epoxidase, Lanosterol 14α-demethylase (CYP51), Sigma non-opioid intracellular receptor 1.

Targets

Squalene epoxidase · Lanosterol 14α-demethylase (CYP51) · Sigma non-opioid intracellular receptor 1

Marketed (5)

Phase 3 pipeline (6)